New Research Related to Breastfeeding Late Preterm Infants with Spina Bifida

The Fetal Heart Program at CHOP is one of the first programs in the world to begin incorporating provocative testing with maternal hyperoxygenation in our fetal echocardiography imaging suite.

The Fetal Heart Program provides comprehensive, compassionate care that addresses the medical as well as psychosocial effects of a family’s experience in the setting of a fetal congenital heart disease diagnosis.

Data collected by CHOP's new Birth Defects Biorepository will be used to investigate factors that may cause birth defects and that may modify the long-term outcomes.

This case highlights the complex, multidisciplinary care required for prenatal management, delivery and immediate cardiac intervention for pulmonary arterio-venous fistula (PAVF).

Two scientists at CHOP have received highly competitive five-year grants from the National Institutes of Health to advance innovative research on the leading edge of biomedicine.

The event drew more than 2,500 patients and families who were treated in the Center for Fetal Diagnosis & Treatment to reconnect with their clinicians and other families who share an indescribable bond.

CHOP/Penn Medicine animal study published in Science Translational Medicine shows promise for developing new therapies for treating lethal lung diseases.

Fox 6 News reports on patient who underwent fetal surgery midway through his mother’s pregnancy.

Jayant’s parents, Suni and Emily, temporarily relocated to Philadelphia to ensure their unborn son received the best care possible.